PI3K Inhibitor BKM120, Carboplatin, and Pemetrexed Disodium in Treating Patients With Stage IV Non-Small Cell Lung Cancer
Conditions
- Recurrent Non-small Cell Lung Cancer
- Stage IV Non-small Cell Lung Cancer
Interventions
- DRUG: PI3K inhibitor BKM120
- DRUG: pemetrexed disodium
- DRUG: carboplatin
- OTHER: laboratory biomarker analysis
- OTHER: pharmacological study
- PROCEDURE: quality-of-life assessment
Sponsor
City of Hope Medical Center
Collaborators